See All Slides - tctmd.com

Slides

Presentation TCT 2014

MitrAssist TMVR

Presenter: Francesco Maisano, Gregg W. Stone, Brian K. Whisenant, Peter J. Fitzgerald

September 14, 2014

Presentation TCT 2014

For the Proposal!

Presenter: Mehdi H. Shishehbor

September 14, 2014

Presentation TCT 2014

Cardiac Implants

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, David L. Brown, Karl-Heinz Kuck

September 14, 2014

Presentation TCT 2014

Does Cilostazol Have a Role as an Antiplatelet Agent in the Contemporary DES Era (and in Triple Therapy Decisions)?

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Frederick Feit

September 14, 2014

Presentation TCT 2014

The MitraSpacer

Presenter: Francesco Maisano, Gregg W. Stone, Brian K. Whisenant, Lars G. Svensson

September 14, 2014

Presentation TCT 2014

Pulmonary Artery Denervation for Pulmonary Hypertension: Results, Case Example, and Future Directions

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Shao Liang Chen

September 14, 2014

Presentation TCT 2014

No: Vorapaxar Is Effective, but Prasugrel and Ticagrelor are Preferred!

Presenter: Dirk Sibbing

September 14, 2014

Presentation TCT 2014

Case Study: DES in a High Bleeding Risk Patient with Complex Coronary Artery Disease

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Robert A. Byrne

September 14, 2014

Presentation TCT 2014

The Five Echocardiographic Essentials for Optimal TAVR

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Rebecca T. Hahn

September 14, 2014

Presentation TCT 2014

Adjustable Valves (Micardia and Others): From Surgical to Transcatheter Implants

Presenter: Francesco Maisano, Gregg W. Stone, Brian K. Whisenant, Maurice Buchbinder

September 14, 2014

Advertisement

Slides

MitrAssist TMVR

For the Proposal!

Cardiac Implants

Does Cilostazol Have a Role as an Antiplatelet Agent in the Contemporary DES Era (and in Triple Therapy Decisions)?

The MitraSpacer

Pulmonary Artery Denervation for Pulmonary Hypertension: Results, Case Example, and Future Directions

No: Vorapaxar Is Effective, but Prasugrel and Ticagrelor are Preferred!

Case Study: DES in a High Bleeding Risk Patient with Complex Coronary Artery Disease

The Five Echocardiographic Essentials for Optimal TAVR

Adjustable Valves (Micardia and Others): From Surgical to Transcatheter Implants

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content